🇺🇸 FDA
Patent

US 7855221

Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

granted A61PA61P13/12A61P43/00

Quick answer

US patent 7855221 (Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid) held by Theravance, Inc. expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P13/12, A61P43/00, A61P9/00, A61P9/04